Columbia Dividend Income Fund Institutional Class (GSFTX)
Fund Assets | 12.29B |
Expense Ratio | 0.65% |
Min. Investment | $2,000 |
Turnover | n/a |
Dividend (ttm) | 1.99 |
Dividend Yield | 5.96% |
Dividend Growth | 31.81% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Dec 12, 2024 |
Previous Close | 33.06 |
YTD Return | -0.45% |
1-Year Return | 7.46% |
5-Year Return | 111.11% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 79 |
Inception Date | Mar 4, 1998 |
About GSFTX
The Fund's investment strategy focuses on Equity Income with 0.69% total expense ratio. The minimum amount to invest in Columbia Funds Series Trust I: Columbia Dividend Income Fund; Institutional Class Shares is $2,000 on a standard taxable account. Columbia Funds Series Trust I: Columbia Dividend Income Fund; Institutional Class Shares seeks total return, consisting of current income and capital appreciation. Normally, the Fund invests at least 80% of its net assets in a diversified portfolio of income-producing equity securities, which will consist primarily of common stocks but also may include preferred stocks and convertible securities.
Performance
GSFTX had a total return of 7.46% in the past year. Since the fund's inception, the average annual return has been 8.70%, including dividends.
Top 10 Holdings
27.50% of assetsName | Symbol | Weight |
---|---|---|
JPMorgan Chase & Co. | JPM | 4.64% |
Microsoft Corporation | MSFT | 3.30% |
Walmart Inc. | WMT | 3.15% |
UnitedHealth Group Incorporated | UNH | 2.70% |
The Home Depot, Inc. | HD | 2.46% |
Johnson & Johnson | JNJ | 2.45% |
Broadcom Inc. | AVGO | 2.40% |
AbbVie Inc. | ABBV | 2.19% |
Exxon Mobil Corporation | XOM | 2.12% |
Bank of America Corporation | BAC | 2.09% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 12, 2024 | $1.54269 | Dec 12, 2024 |
Sep 20, 2024 | $0.1478 | Sep 20, 2024 |
Jun 21, 2024 | $0.15002 | Jun 21, 2024 |
Mar 20, 2024 | $0.14724 | Mar 20, 2024 |
Dec 13, 2023 | $1.07555 | Dec 13, 2023 |
Sep 21, 2023 | $0.13557 | Sep 21, 2023 |